Woman sues drug company
http://www.thestar.co.uk/news/Woman-sues-drug-company.5314918.jp
Published Date: 29 May 2009By Kate LahiveA THIRD Sheffield resident is launching legal action against pharmaceutical company GlaxoSmithKline UK.The woman, who lives in Greystones, is seeking compensation for undisclosed personal injuries after taking the widely prescribed anti-depressant drug Seroxat which is manufactured by the global company.She is claiming up to £50,000 in compensation from GlaxoSmithKline UK.She is one of several hundred people, including a woman, from Stannington, and a man, from Firth Park, who are planning to sue the drug manufacturer, claiming their lives have been blighted by the anti-depressant.Seroxat, also known as paroxetine, is designed to restore the taker's happiness and confidence.But some users have claimed they became addicted to the medication while others say they experienced suicidal thoughts.The case is being considered by a judge but is not expected to be concluded until next year.GlaxoSmithKline is contesting the legal action and a spokesman has previously said there was "no merit" in the litigation
http://www.thestar.co.uk/news/Woman-sues-drug-company.5314918.jp
Published Date: 29 May 2009By Kate LahiveA THIRD Sheffield resident is launching legal action against pharmaceutical company GlaxoSmithKline UK.The woman, who lives in Greystones, is seeking compensation for undisclosed personal injuries after taking the widely prescribed anti-depressant drug Seroxat which is manufactured by the global company.She is claiming up to £50,000 in compensation from GlaxoSmithKline UK.She is one of several hundred people, including a woman, from Stannington, and a man, from Firth Park, who are planning to sue the drug manufacturer, claiming their lives have been blighted by the anti-depressant.Seroxat, also known as paroxetine, is designed to restore the taker's happiness and confidence.But some users have claimed they became addicted to the medication while others say they experienced suicidal thoughts.The case is being considered by a judge but is not expected to be concluded until next year.GlaxoSmithKline is contesting the legal action and a spokesman has previously said there was "no merit" in the litigation
No comments:
Post a Comment
Note: only a member of this blog may post a comment.